منابع مشابه
A neurobehavioral approach for treatment of complex partial epilepsy: efficacy
This is a retrospective study of the efficacy of a short-term comprehensive multidisciplinary neurobehavioral treatment approach for complex partial epilepsy. Eleven patients were treated intensively for five consecutive days followed by 6 months of weekly telephone contact and an additional 6 months of monitoring of seizure logs and journals. Data was analysed at least 24 months after initiati...
متن کاملChallenges in the Treatment of Epilepsy
Epilepsy is one of the most important diseases of nervous system that involves 0.5-1% of the population. In spite of new developments in antiepileptic drugs, between 20-30% of epileptic patients can not be controlled and even those who are controlled with antiepileptic drugs suffer from their adverse events. Epileptic patients have different challenges in relation to the disease and its medicat...
متن کاملبیماری صرع از منظر جرم شناسی (the criminology of the epilepsy)
ارتکاب جرم یکی از خطرات زندگی انسان می باشد.از آنچه که در طول تحقیق بیان شد چنین استنباط می شود که موضوع مشترک جرم شناسی وحقوق کیفری جرم است،جرم شناس درمورد هربزهکارمی کوشد تا پرونده شخصیت او را تنظیم کند به این معنی که شخصیت و منش تبهکار را مد نظر قرار دهد و اوضاع شخصی او را که در تکوین شخصیت او موثر بوده بررسی نماید.از این رو علم جرم شناسی در راستای مقابله با این مخاطرات به شناسایی علل جرم و ...
15 صفحه اولO25: Treatment of Autoimmune Epilepsy
Seizure and epilepsy can be related to autoimmune diseases and processes. Accurate diagnosis is essential for better treatment of these conditions. Different clinical studies have been conducted to diagnose and treat autoimmune epilepsy. Rapid treatment of these diseases helps to Improve prognosis and less relapses. Conventional epilepsy treatments including antiepileptic drugs are less success...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Clinical Neuropsychology
سال: 1997
ISSN: 0887-6177,1873-5843
DOI: 10.1093/arclin/12.1.91